Fortis Healthcare is prioritizing obesity treatment and developing obesity clinics throughout India to address increasing demand for weight-loss drugs and therapies.The initiative is taking place as India is set to be the world's second-largest...
Maxivision Super Speciality Eye Hospitals, one of India’s fastest-growing eye care chains, launches a first-of-its-kind initiative in Madhapur, Hyderabad to address the rapidly growing problem of myopia, furthering its mission to combat the...
First-of-its-kind digital health programme on Vidal Health’s platform will offer an end- to-end, convenient and cashless experience, making HPV vaccine more accessible Collaboration is part of Vidal Health’s efforts to provide preventive
.jpeg "Indian Pharma Targets Rs 800 Cr Insulin Pen Market Post Novo")
Novo Nordisk's declaration to put an end to its Penfill and FlexPen products in India by December 2023, Indian pharmaceutical companies like Eris Lifesciences, Wockhardt, and Lupin, are getting ready to capitalize the local human insulin
Alkem Laboratories announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar that has been developed in India and can be used in HER2-positive breast cancer. With this achievement, Alkem aims to provide better access to...
The first comprehensive worldwide framework created to guarantee access to controlled drugs for medical and scientific uses while reducing the risks to public health that may arise from misuse and diversion was released by the World Health
Akums Drugs & Pharmaceuticals highlights lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings. Recognized for its broad clinical applicability,
The opening of a new glass tubing factory in Telangana by Corning Incorporated and SGD Pharma would increase pharmaceutical production in the area. The new facility will help address capacity issues and quality requirements in primary glass packaging
Pfizer Inc. revealed that it is acquiring Metsera, Inc. for $4.9 billion in cash, further enhancing its pipeline in obesity and cardio-metabolic diseases. The definitive agreement was approved unanimously by both companies' boards and is a...
Hetero Healthcare Ltd., one of the most prominent Indian pharmaceutical companies, in collaboration with Enzene Biosciences Ltd., has announced the introduction of Perzea, their cheapest biosimilar of Pertuzumab.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")